These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22315840)

  • 1. Barrett's metaplasia in Indian obese male patients with gastro-oesophageal reflux disease.
    Bamanikar AA; Diwan AG; Benoj DE; Bamanikar SA
    J Indian Med Assoc; 2011 Jul; 109(7):483-4. PubMed ID: 22315840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
    Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
    Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
    Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
    Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reflux disease and Barrett's oesophagus - are there gender-specific differences?].
    Endlicher E; Gelbmann CM; Messmann H
    Z Gastroenterol; 2009 Oct; 47(10):1065-8. PubMed ID: 19809958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of intestinal metaplasia in patients with and without peptic strictures.
    Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP
    Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
    Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication?
    Cowgill SM; Al-Saadi S; Villadolid D; Zervos EE; Rosemurgy AS
    Am J Surg; 2006 Nov; 192(5):622-6. PubMed ID: 17071195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
    Eisen GM; Sandler RS; Murray S; Gottfried M
    Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Barrett's esophagus in Indian patients with gastroesophageal reflux disease.
    Mathew P; Joshi AS; Shukla A; Bhatia SJ
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1151-6. PubMed ID: 21375585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.